Forum Rewind 2023

Publication Highlights

Running Through Life With Purpose and Grace A doctor who survived both stage IV cancer and heart failure now teaches her patients how to live life to the fullest. Page 4

Attacking Colorectal Cancer: Latest Updates For Treating Patients New advancements and implementation of sequencing technologies is improving outcomes. Page 4

The Current and Future State of Medically Integrated Pharmacy Accreditation Three practices share their experiences with the NCODA Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation program. Page 5

KRASh Course in KRASG12C Inhibitors and Dose-Rounding Protocols A summary of indications, dosing, monitoring and adverse effects of KRAS inhibitors, plus a look at the risks and benefits of dose rounding. Page 5

The Development of Immunotherapy and Immunology in Cancers & What Pharmacy Technicians Need to Know About Step Therapy An overview of the general classes and mechanism of action for contemporary immunotherapy in oncology practice. Page 6

Considerations When Caring for LGBTQIA+ Patients A discussion of the LGBTQIA+ community and their care, as well as the importance of healthcare workers being properly educated to provide an equal level of healthcare to LGBTQIA+ patients. Page 7

Oral Anticancer Medication (OAM) Monitoring Discussion of the significance and need for implementation of nursing-specific therapeutic strategies and workflows in the monitoring of OAMs. Page 7

Value-Based Care: Looking into the Future A look at the advantages of value-based care and the oncology care model (OCM) have over the current model of fee-for-service care. Page 8

Sarcoma Management In The Adolescent & Young Adult Population A discussion of the unexplained drop in survival in the AYA population. Page 8

Breaking Down the Inflation Reduction Act While patients will experience savings, undesired outcomes have been predicted for manufacturers and cancer care providers. Page 9

Cardio-Oncology Pearls & Nutrition in GI Oncology A summary of cardiac dysfunction related to five different classes of cancer treatment and barriers to nutrition intake in patients with GI cancers. Page 9

Understanding Updates to USP 797 and 800 Revisions to USP 797 and 800, including standards for sterile and hazardous drugs designed to protect both patients and healthcare workers. Page 10

Oncology Pharmacy Technician Certification Prep OPTA’s new 12-month certification program encompasses core oncology pharmacy training plus clinical oncology skills and patient management. Page 10

Toxicity Management for CAR-T and Bispecific Treatment An overview of the mechanism of action for CAR-T and bispecific T-cell engager (BiTE) therapies, plus tips on managing toxicities. Page 11

Ins & Outs of Managing Financial Assistance & Prior Authorizations Dealing with prior authorization and how to help patients save with oncolytic therapies. Page 11